Andere Kunden interessierten sich auch für
![Adverse Drug Reactions To Highly Active Antiretroviral Therapy (HAART)]( "Adverse Drug Reactions To Highly Active Antiretroviral Therapy (HAART)")
Adverse Drug Reactions To Highly Active Antiretroviral Therapy (HAART)35,99 €![The hypoglycemic active protein of alfalfa (Medicago sativa)]( "The hypoglycemic active protein of alfalfa (Medicago sativa)")
The hypoglycemic active protein of alfalfa (Medicago sativa)35,99 €![Quinazoline and Thiazoloquinazoline - A Biologically Active Scaffold]( "Quinazoline and Thiazoloquinazoline - A Biologically Active Scaffold")
Quinazoline and Thiazoloquinazoline - A Biologically Active Scaffold66,99 €![Pharmacovigilance on Antiretroviral Therapy]( "Pharmacovigilance on Antiretroviral Therapy")
Pharmacovigilance on Antiretroviral Therapy42,99 €![Characterization of bio-active molecule from Andrographis paniculata]( "Characterization of bio-active molecule from Andrographis paniculata")
Characterization of bio-active molecule from Andrographis paniculata35,99 €![Survey of active pharmaceutical ingredients-excipient incompatibility]( "Survey of active pharmaceutical ingredients-excipient incompatibility")
Survey of active pharmaceutical ingredients-excipient incompatibility35,99 €![Global Medical Device Regulation: Emphasis on Active Implants]( "Global Medical Device Regulation: Emphasis on Active Implants")
Global Medical Device Regulation: Emphasis on Active Implants44,99 €
Discontinuation of, or outright defaulting on highly active antiretroviral therapy (HAART) by HIV-positive patients is harmful, and so is periodic unintentional non-adherence or treatment interruption. The resulting harm is especially more pronounced in sub-Saharan Africa where most individuals start HAART in advanced stages of the disease. Discontinuing patients could spread drug resistant virus to other individuals.